The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
|ClinicalTrials.gov Identifier: NCT01832558|
Recruitment Status : Unknown
Verified March 2016 by Marcus Saemann, Medical University of Vienna.
Recruitment status was: Recruiting
First Posted : April 16, 2013
Last Update Posted : March 16, 2016
Medical University of Vienna
Information provided by (Responsible Party):
Marcus Saemann, Medical University of Vienna
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
Shavit L, Lifschitz MD, Epstein M. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Kidney Int. 2012 May;81(10):955-68. doi: 10.1038/ki.2011.505. Epub 2012 Feb 15. Review.